Global Clostridium Butyricum Market Insights, Forecast to 2028

Over the last few years, the global demand for probiotic 3 has increased at a moderate rate in the end-use industries as increasing number of people are becoming health conscious across developed and emerging economies. As a result, increasing demand for probiotic is estimated to create lucrative opportunities for the global clostridium butyricum market in the near future.
Clostridium butyricum is a probiotic bacteria or butyric acid used as an ingredient in many end-use industries.
Market Analysis and Insights: Global Clostridium Butyricum Market
Due to the COVID-19 pandemic, the global Clostridium Butyricum market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Plant-based accounting for % of the Clostridium Butyricum global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Pharmaceuticals segment is altered to an % CAGR throughout this forecast period.
China Clostridium Butyricum market size is valued at US$ million in 2021, while the US and Europe Clostridium Butyricum are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Clostridium Butyricum landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Clostridium Butyricum include AOR Canada, Miyarisan Pharmaceutical Co., Ltd, MITUSHI BIO PHARMA and Hangzhou Vega Co., Ltd, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
In terms of production side, this report researches the Clostridium Butyricum capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Clostridium Butyricum by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Global Clostridium Butyricum Scope and Segment
Clostridium Butyricum market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Clostridium Butyricum market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Plant-based
Animal-based
Segment by Application
Pharmaceuticals
Biotech
Food & Beverages
Ntraceuticals
Animal Feed
Cosmetics & Personal Care
By Company
AOR Canada
Miyarisan Pharmaceutical Co., Ltd
MITUSHI BIO PHARMA
Hangzhou Vega Co., Ltd
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E